Compare NRT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRT | RPID |
|---|---|---|
| Founded | 1975 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 84.8M |
| IPO Year | 1995 | 2021 |
| Metric | NRT | RPID |
|---|---|---|
| Price | $8.83 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 34.7K | ★ 275.8K |
| Earning Date | 05-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.18% | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ 0.70 | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | $12.53 | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $5.23 | $1.09 |
| 52 Week High | $10.49 | $4.94 |
| Indicator | NRT | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | N/A |
| Support Level | $8.48 | N/A |
| Resistance Level | $9.52 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 24.05 | 0.00 |
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.